{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:41:41Z","timestamp":1790412101770,"version":"4.1.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1097\/iae.0b013e3181f57d58","type":"journal-article","created":{"date-parts":[[2010,10,5]],"date-time":"2010-10-05T05:16:27Z","timestamp":1286255787000},"page":"1405-1411","source":"Crossref","is-referenced-by-count":77,"title":["INTRAVITREAL BEVACIZUMAB DURING PREGNANCY"],"prefix":"10.1097","volume":"30","author":[{"given":"Ryan M","family":"Tarantola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C","family":"Folk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Culver","family":"Boldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit B","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210130","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/01.iae.0000225766.75009.3a","article-title":"Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"26","author":"Rich","year":"2006","journal-title":"Retina"},{"key":"R2-8-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/01.iae.0000238561.99283.0e","article-title":"Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.","volume":"26","author":"Spaide","year":"2006","journal-title":"Retina"},{"key":"R3-8-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ophtha.2005.11.019","article-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R4-8-20210130","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/bjo.2006.099598","article-title":"The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.","volume":"90","author":"Fung","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"R5-8-20210130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00417-007-0660-z","article-title":"Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).","volume":"246","author":"Wu","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-8-20210130","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0420.2007.01067.x","article-title":"Complications in patients after intravitreal injection of bevacizumab.","volume":"86","author":"Shima","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"R7-8-20210130","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.ophtha.2007.03.043","article-title":"Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.","volume":"114","author":"Chan","year":"2007","journal-title":"Ophthalmology"},{"key":"R8-8-20210130","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1001\/archopht.125.11.1487","article-title":"Intravitreal bevacizumab for subfoveal idiopathic choroidal neovascularization.","volume":"125","author":"Mandal","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"R9-8-20210130","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.eye.6702941","article-title":"Intravitreal bevacizumab for treatment of choroidal neovascularization secondary to angioid streaks.","volume":"22","author":"Apte","year":"2008","journal-title":"Eye (Lond)"},{"key":"R10-8-20210130","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/IAE.0b013e31815e9834","article-title":"Intravitreal bevacizumab (Avastin) injection as primary treatment of inflammatory choroidal neovascularization.","volume":"27","author":"Adan","year":"2007","journal-title":"Retina"},{"key":"R11-8-20210130","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ajo.2007.02.039","article-title":"Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.","volume":"143","author":"Chan","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R12-8-20210130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ajo.2007.12.030","article-title":"Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosis.","volume":"145","author":"Schadlu","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R13-8-20210130","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s00417-007-0636-z","article-title":"Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin).","volume":"245","author":"Ahmadieh","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-8-20210130","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.ophtha.2006.11.028","article-title":"Intravitreal bevacizumab for treatment of uveitic macular edema.","volume":"114","author":"Cordero Coma","year":"2007","journal-title":"Ophthalmology"},{"key":"R15-8-20210130","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00417-006-0512-2","article-title":"Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin).","volume":"245","author":"Ziemssen","year":"2007","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R16-8-20210130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IAE.0b013e31802eff83","article-title":"Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study.","volume":"27","author":"Costa","year":"2007","journal-title":"Retina"},{"key":"R17-8-20210130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bjo.2008.141085","article-title":"Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial.","volume":"93","author":"Prager","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R18-8-20210130","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"R19-8-20210130","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-008-0774-y","article-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR).","volume":"246","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-8-20210130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/IAE.0b013e318176de48","article-title":"Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.","volume":"28","author":"Kook","year":"2008","journal-title":"Retina"},{"key":"R21-8-20210130","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2005.10.017","article-title":"Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer.","volume":"23","author":"Hurwitz","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-8-20210130","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa061884","article-title":"Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer.","volume":"355","author":"Sandler","year":"2006","journal-title":"N Engl J Med"},{"key":"R23-8-20210130","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1200\/JCO.2007.12.2440","article-title":"Bevacizumab plus irinotecan in recurrent glioblastoma multiforme.","volume":"25","author":"Vredenburgh","year":"2007","journal-title":"J Clin Oncol"},{"key":"R24-8-20210130","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"},{"key":"R25-8-20210130","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(07)61904-7","article-title":"Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.","volume":"370","author":"Escudier","year":"2007","journal-title":"Lancet"},{"key":"R26-8-20210130","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrclinonc.2009.94","article-title":"Adverse effects of anticancer agents that target the VEGF pathway.","volume":"6","author":"Chen","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"R27-8-20210130","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00417-008-0874-8","article-title":"Vascular endothelial growth factor in fellow eyes of eyes injected with intravitreal bevacizumab.","volume":"246","author":"Sawada","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R28-8-20210130","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.ophtha.2007.01.017","article-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin).","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"R29-8-20210130","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","article-title":"A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity.","volume":"148","author":"Micieli","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R31-8-20210130","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies.","volume":"86","author":"Pentsuk","year":"2009","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"R32-8-20210130","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/eye.2008.218","article-title":"Exposure to verteporfin and bevacizumab therapy for choroidal neovascularization secondary to punctate inner choroidopathy during pregnancy.","volume":"23","author":"Rosen","year":"2009","journal-title":"Eye (Lond)"},{"key":"R34-8-20210130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy.","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"R35-8-20210130","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/S0264-410X(03)00336-0","article-title":"Transfer of antibody via mothers milk.","volume":"21","author":"Van de Perre","year":"2003","journal-title":"Vaccine"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-201010000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:38:04Z","timestamp":1786041484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-201010000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e3181f57d58","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}